Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 9,999 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: TARGET Clear all

Conditions: Diabetes Mellitus
Interventions: InPen Smart insulin pen, traditional/standard insulin pen; Device · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Diabetes Mellitus, Type 1
Interventions: insulin, human insulin inhalation powder (HIIP); Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 25
States / cities: San Diego, California • Denver, Colorado • Hollywood, Florida + 22 more

Conditions: Solid Tumor, Leukemia, Lymphoma, Brain Tumor
Interventions: IMPACT, ESO; Behavioral · Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 0 Years to 18 Years
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 3
States / cities: Cincinnati, Ohio • Dayton, Ohio • Oklahoma City, Oklahoma

Conditions: Alcoholism
Interventions: Perampanel, Placebo; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 21 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 4
States / cities: Farmington, Connecticut • New Haven, Connecticut • West Haven, Connecticut + 1 more

Conditions: Vaccine Hesitancy
Interventions: INVEST; Other
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Durham, North Carolina • Columbia, South Carolina

Conditions: Prostate Cancer, PSA, Infection
Interventions: Systematic Transrectal biopsy (TR-Bx), Targeted Transrectal biopsy (TR-Bx), Systematic Transperineal biopsy (TP-Bx), Targeted Transperineal biopsy (TP-Bx); Procedure
Lead sponsor: Albany Medical College; Other
Eligibility: Male only
Enrollment: 840 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Albany, New York

Conditions: Oppositional Defiant Disorder, Insomnia Chronic
Interventions: NiteCAPP SINCC; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 8 Years to 17 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Alcohol Use Disorder (AUD)
Interventions: Zonisamide, Placebo; Drug
Lead sponsor: Washington State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 205 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Pulmonary Arterial Hypertension
Interventions: Pemziviptadil (PB1046) Injection; Drug
Lead sponsor: PhaseBio Pharmaceuticals Inc.; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 16
States / cities: La Jolla, California • Sacramento, California • Miami, Florida + 10 more

Conditions: Cognitive Aging, Alzheimer Disease, Protection Against
Interventions: Active NIR-PBM, Sham NIR-PBM; Device
Lead sponsor: University of Florida; Other
Eligibility: 65 Years to 89 Years
Enrollment: 168 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 2
States / cities: Tucson, Arizona • Gainesville, Florida

Conditions: Obsessive-Compulsive Disorder, Obsessive-compulsive Disorders and Symptoms
Interventions: Cognitive bias modification for interpretation bias, Psychoeducation, Approach avoidance training, Inactive sham approach avoidance training; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Unilateral Spatial Neglect, Stroke
Interventions: Prism adaptation training combined with TENS, PAT only; Device · Other
Lead sponsor: Kettering Health Network; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Centerville, Ohio

Conditions: Colonic Neoplasms, Colorectal Neoplasms
Interventions: GRT-C901, GRT-R902, Atezolizumab, Ipilimumab, Adjuvant chemotherapy; Drug
Lead sponsor: Gritstone bio, Inc.; Industry
Eligibility: 12 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 3
States / cities: Detroit, Michigan • New York, New York • Cincinnati, Ohio

Conditions: Low Back Pain
Interventions: Exercise, Spinal Manipulation, Neuroemotional Technique (NET); Behavioral · Procedure
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 20 Years to 49 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Pediatric ALL
Interventions: Survey 1, Survey 2; Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 1 Day to 21 Years
Enrollment: 6,341 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gout
Interventions: Pegloticase, methotrexate, placebo, folic acid, gout flare prophylaxis regimen, fexofenadine, acetaminophen, methylprednisolone; Biological · Drug · Dietary Supplement
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 60
States / cities: Birmingham, Alabama • Anchorage, Alaska • Flagstaff, Arizona + 54 more

Conditions: Crohn Disease (CD)
Interventions: Tirzepatide, Standard of care treatment; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 3
States / cities: Beverly Hills, California • St Louis, Missouri • New York, New York

Conditions: Motor Activity
Interventions: Motor Learning, Somatosensory Learning, Observational Task, Mental Imagery, transcranial direct current stimulation; Behavioral · Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy
Interventions: transcranial focused ultrasound (tFUS); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Asthma
Interventions: Apieron Insight eNO monitor; Device
Lead sponsor: Apieron; Industry
Eligibility: 12 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 12
States / cities: Mission Viejo, California • San Jose, California • Glastonbury, Connecticut + 9 more

Conditions: Coronary Artery Disease
Interventions: Resolute Integrity Stent; Device
Lead sponsor: Medtronic Vascular; Industry
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Juvenile Idiopathic Arthritis
Interventions: Sleep Innovations for Preschoolers with Arthritis (SIPA); Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 2 Years to 5 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Haemostasis, Healthy
Interventions: warfarin, eptacog alfa (activated), placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Overland Park, Kansas

Search by objective public record fields.

Improving Glycemic Control With Telemedicine and Smart Insulin Pens

Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.

Illness Management and Parental Adjustment to Cancer Treatment

Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence

Increasing Vaccine Uptake Among Adolescents in the Rural South

Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications

Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)

Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury

The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004

The Revitalize Study in Older Adults at Risk for Alzheimer's Disease

Cognitive Bias Modification for OCD

Comparing Prism Adaptation Training With and Without TENS to Minimize Unilateral Spatial Neglect

Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer

Pregnancy-Related Low Back Pain and Complementary and Alternative Medicine (CAM) Treatment

Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics

Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

Investigating Motor Cortex Processing for Pain Modulation

Transcranial Focused Ultrasound (tFUS) Modulation of Reward Network

Management of Asthma Patients Guided by Exhaled Nitric Oxide (eNO)

Resolute Integrity US Extended Length Sub-Study(RI US XL)

Sleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management Intervention

Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment